Showing posts with label TSH. Show all posts
Showing posts with label TSH. Show all posts

Thursday, 26 October 2023

Inflammatory Indicators Associated with Hypothyroidism | Chapter 9 | Advanced Concepts in Medicine and Medical Research Vol. 1

 Emerging controlled evidence has suggested that changed thyroid hormones can influence lipid metabolism and lead to dyslipidemia in hypothyroid sufferers. Inflammatory markers are more important factors to recognize and prognoses the status of hypothyroidism. Hypothyroidism is a dispassionate syndrome resulting from the inadequacy of thyroid hormones, which results from lowered secretion of both T4 (thyroxine) and T3 (triiodothyronine), heedless of the cause, resulting in a statement slowing unhappy of metabolic processes. Numerous findings suggest that hypothyroidism was a very influenced accompanying TNF-α, IL 6, and IL 1. In this chapter, we review the role of instigative markers in hypothyroidism. It seems that for early disease and prevention, these markers maybe used in hypothyroidism so that improve their prognosis.

Author(s) Details:

Jaswant Kaur,
Department of Biochemistry, Dr. S.S. Tantia Medical College, Hospital & Research Center, Sri Ganganagar, India.

Mridula Mittal,
Department of Physiology, Adesh Medical College, Bathinda, Punjab, India.

Jaspreet Kaur,
Department of Biochemistry, North Delhi Municipal Corporation Medical College, Hindu Rao Hospital, Malka Ganj, New Delhi, India.

Navdeep Kaur,
Department of Biochemistry, Acharya Shri Chander College of Medical Sciences and Hospital, Jammu, India.

Rajesh Kumar,
Department of Anatomy, NC Medical College & Hospital, Panipat, Haryana, India.

Rishu,
Department of Microbiology, Guru Gobind Singh Government Medical College, Faridkot, India.

Please see the link here: https://stm.bookpi.org/ACMMR-V1/article/view/12306

Tuesday, 29 November 2022

Role of Minerals, Magnesium and Zinc in Subclinical Hypothyrodisim| Chapter 9 | Current Topics on Chemistry and Biochemistry Vol. 6

 This study aim to estimate the levels of antitoxin magnesium and zinc in inmates of Subclinical Hypothyroidism (SCH). SCH, according to the endocrine netting is defined as an promotion in Thyroid Stimulating Hormone (TSH) level (4.6-10 m I U/L) with thyroid birth control method levels in the normal range. The party needs magnesium (Mg+2), a macromineral that serves as a cofactor for more than 300 enzymes. For 5'-deiodinase to work correctly and as a cofactor for thyrotropin-surrendering hormone (TRH), metallic mineral (Zn+2) is necessary. The thyroid hormones that copy factors bind to and involve Zn+2 bound to cysteine residues are essential for modulating deoxyribonucleic acid expression.To recognize the instances with SCH, the antitoxin TSH, Total Triiodothyronine (T3), and Thyroxine (T4) levels were determined utilizing the ELISA method. By spectrophotometry, a semiautomated analyst was used to determine the antitoxin magnesium concentration. Patients accompanying SCH had their serum metallic mineral judged using a sufficiently automated analyst (Vitros 5600).In SCH, both T3, T4 were inside the normal range, and TSH was in the range of 4.6-10 mI U/L. There was a statistically meaningful (p0.001) drop in antitoxin zinc levels, but not in antitoxin magnesium levels in patients accompanying subclinical hypothyroidism.

Author(s) Details:

Thuraya Abdulsalam A. A. Al-Azazi,
Department of Biochemistry, School of Medical Sciences and Research and Sharda Hospital, Sharda University, Greater Noida, Uttar Pradesh, India.

Shaliza Verma,
Department of Biochemistry, School of Medical Sciences and Research and Sharda Hospital, Sharda University, Greater Noida, Uttar Pradesh, India.

Rajesh Kr Thakur,
Department of Biochemistry, School of Medical Sciences and Research and Sharda Hospital, Sharda University, Greater Noida, Uttar Pradesh, India.

Manoj Kumar Nandkeoliar,
Department of Biochemistry, School of Medical Sciences and Research and Sharda Hospital, Sharda University, Greater Noida, Uttar Pradesh, India.

V. P. S. Punia,
Department of Medicine, School of Medical Sciences and Research and Sharda Hospital, Sharda University, Greater Noida, Uttar Pradesh, India.

B. C. Kabi,
Department of Biochemistry, School of Medical Sciences and Research and Sharda Hospital, Sharda University, Greater Noida, Uttar Pradesh, India.

Please see the link here: https://stm.bookpi.org/CTCB-V6/article/view/8777




Saturday, 12 March 2022

Assessing the Variation of Certain Haemostatic Parameters in Hypothyroidism | Chapter 11 | Emerging Trends in Disease and Health Research Vol.4.

 The purpose of this research is to see how hypothyroidism affects specific haemostatic measures. Thyroid issues, which are more common in women, have been reported to affect the coagulation-fibrinolytic system. The goal of this study is to see if there are any changes in specific haemostatic measures in overt hypothyroid individuals.

With a sample size of 15, hypothyroid individuals and controls were measured for bleeding time, clotting time, and platelet count. Subjects in the hypothyroid group had low FT3, FT4, and an increased TSH level (mean 14.9 mU/L). Both groups were similar in age and gender. The findings revealed that bleeding time and clotting time were both statistically significant, with p-values of 0.0001 for each parameter. When compared to the control group, the hypothyroid group had a lower platelet count, which was statistically significant with a p-value of 0.0001. This discovery was in contrast to numerous earlier research, which found either an increase in platelet count or a statistically insignificant decrease in platelet count.
In overt hypothyroid patients, this indicates an elevated bleeding tendency or hypocoagulable state. The greater the divergence of haemostatic parameters from normal, the higher the TSH levels. Unraveling the effect of thyroid hormone changes on haemostatic parameters, as well as the mechanisms involved, may lead to more treatment choices for altered parameters, reducing the risk of catastrophic repercussions.

Author(s) Details:

Lanke Vani,
Department of Physiology, Guntur Medical College, Guntur, A.P, India.

Please see the link here: https://stm.bookpi.org/ETDHR-V4/article/view/6054

Friday, 6 November 2020

A Mini Review on the Thyroid Function Status by Paired Test| Chapter 11 | Current Topics in Medicine and Medical Research Vol. 8

 By combining their reference ranges, we classified a population of 34159 FT4 & TSH paired test results. This established 9 groups and the association between them with class-specific hormonal ranges. The euthyroid population (24722) with normal FT4 and TSH had FT4 & TSH respectively (14.83-14.90 pmol / ml) and (2.40-2.43 μIU / ml). A case-alone FT4 can classify the class because a class's FT4 has a substantial mean difference from all the remaining 8 classes (sig < .002) except in 2 unique cases that can be overcome by their TSH (sig.000). In all of our classes, there is no clear correlation between FT4 and TSH (r < .445) and so it warns against using TSH alone in diagnostic or follow-up environments. For all thyroid cases with abnormal activity, we conclude that the immediate useful performance of our analysis is the objective of a single biochemical goal. We believe that future research trends should concentrate on searching for individual class aetiology / cause(s) and the accumulated data of such studies can help us understand the phenomenon of shifting functional status of cases with particular aetiology, simplify diagnostic and therapeutic workups, and also establish better treatment protocols for common as well as uncommon & emerging disorders.


Author(s) Details

Prof. Tofail Ahmed

Department of Endocrinology, Bangladesh Institute for Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders, Dhaka, Bangladesh.

View Book :-
https://bp.bookpi.org/index.php/bpi/catalog/book/316  

Assessment of Thyroid Function Status by Paired Test| Chapter 10 | Current Topics in Medicine and Medical Research Vol. 8

 Goal and Methods: We reviewed 34159 test results to understand the usefulness of paired FT4 and TSH tests in assessing Thyroid functional status in diagnostic and follow-up settings. By using the laboratory comparison ranges of FT4 and TSH, we divided the population into all nine possible groups. Then we calculated the frequency of the classes, the FT4 and TSH reference ranges for each class, their mean differences (MD) between classes and the association within a class between FT4 and TSH. Results: The typical FT4 and TSH scale of our euthyroid population is 24722. The mean confidence interval of their FT4 and TSH is 95 percent (14.83-14.90 pmol / ml) and (2.40-2.43 μIU / ml) respectively, and their correlation (r value) is -0.056; sig. Just 0.000. Main Hypo & Hyperthyrodism; Compensated Hypo & Hyperthyrodism; Secondary Hypo & Hyperthyrodism and Isolated Hypo & Hyperthyroximia. The 8 groups of irregular status are with 4 pairs of hypo and hyperthyroximic state. 4 types, namely Primary Hypothyroid, Primary Hyperthyroid, Compensated Hypothyroid and Compensated Hyperthyroid, represent the main bulk of irregular thyroid activity (98.15 percent). The remaining classes are special. Class FT4 has a substantial mean difference from all 8 other classes (sig < .002), with the exception of 2 out of a total of 36 cases. And for their TSH, there are significant MDs in these 2 pairs with non-significant MD for FT4 (sig.000). There is a clear association between FT4 and TSH in none of the 8 groups of abnormal functions (r < -0.5). Only 2 classes of primary hypothyroidism (r = -0.445; Sig. 0.000) and primary hyperthyroidism (r = -0.386; Sig. 0.000) record a mild negative relation. They are not associated in the euthyroid class (r=-0.056; sig. 0.000). Therefore, in diagnostic or follow-up environments, TSH alone should not be used for assessing functional status. Conclusion: 9 classes with class-specific FT4 and TSH ranges and their correlation patterns can be identified by the Paired Test. We conclude that this tool should be used to assess functional status and use Euthyroid's FT4 reference range as the treatment target for abnormally functioning cases.


Author(s) Details

Prof. Tofail Ahmed
Department of Endocrinology, Bangladesh Institute for Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders, Dhaka, Bangladesh.


Professor Hajera Mahtab
Department of Endocrinology, Bangladesh Institute for Research and Rehabilit Disorders, Dhaka, Bangladesh.


Dr. Tania Tofail
Department of Endocrinology, Bhangabando Sheikh Mujibur Medical University, Dhaka, Bangladesh.


Md. A. H. G. Morshed
Endocrinology Laboratory, Diabetic Association of Bangladesh, Dhaka, Bangladesh.


Shahidul A. Khan
Endocrinology Laboratory, Diabetic Association of Bangladesh, Dhaka, Bangladesh.


View Book :- https://bp.bookpi.org/index.php/bpi/catalog/book/316